Administrative Core A
行政核心A
基本信息
- 批准号:10190576
- 负责人:
- 金额:$ 17.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-09-30 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Project Summary/Abstract (Core A, Portnoy)
The purpose of Core A is to ensure scientific progress and promote synergy by providing effective scientific
and administrative leadership and financial oversight to the program. These objectives will be accomplished
by extensive review of scientific progress at monthly meetings attended by all projects and cores within the
program and affiliated lab groups from around the Bay Area; smaller meetings held by subgroups; and
shared interviews of potential postdoctoral fellows. Scientific direction and research results will be subject to
intensive, constructive criticism by investigators within the P01 and by regular evaluations from an external
scientific advisory board. We strongly believe that our extensive collaborative approach promoted by Core A
is unique. Indeed, this program represents the nucleating group for Bay Area investigators studying
intracellular pathogens and innate immunity. The Specific Aims are: 1) Conduct management of scientific
progress; 2) Establish and engage external advisory board to review scientific progress; and 3) Implement
financial management and administrative support. To facilitate interactions among investigators, two-hour
joint lab meetings will continue to be held monthly at UC Berkeley. These monthly meetings consist of
introductory discussions and two scientific presentations from two different labs. Given possible restrictions
related to the coronavirus, we will use teleconferencing options for meetings, if necessary.
The external scientific advisory board, chaired by Dr. Jeffrey F. Miller from UCLA, will provide rigorous and
consistent evaluation of the program’s scientific direction, research results, and progress. Core A will
facilitate the relationship between the external board and the investigators as well as among the Project
Leaders themselves, who will meet once per month for 2 hours in the Program Director’s office. The Portnoy,
Vance, Cox, and Stanley labs each have a weekly lab meeting to review ongoing research in their respective
labs. In addition to the monthly meetings of P01 personnel and other Bay Area labs, there are many other
opportunities for investigators and trainees to interact, exchange ideas, and speak, including a weekly
Division of Immunology & Pathogenesis “Research in Progress” meeting on Mondays at noon with 2
speakers from 2 different labs; a seminar series from the Infectious Diseases & Vaccinology Group on
Mondays at 10 am, most speakers being from local labs; and the Microbial Biology Seminar Series, held on
Wednesdays at noon, with speakers from the US and across the world. Finally, we have an annual
immunology retreat at Asilomar that is held jointly with UCSF. Core A serves as the administrative nucleus
for the P01 and has been a critical element to our success.
项目摘要/摘要(核心A,Portnoy)
核心A的目的是通过提供有效的科学来确保科学进步并促进协同作用
以及该计划的行政领导和财务监督。这些目标将实现
通过对所有项目和核心参加的每月会议上的科学进步进行广泛的审查
来自湾区周围的计划和会员实验室组;亚组举行的较小会议;和
分享了潜在的博士后研究员的采访。科学方向和研究结果将受到
P01中的研究人员以及外部的定期评估
科学咨询委员会。我们坚信,核心A促进了我们广泛的合作方法
是独特的。实际上,该程序代表了研究湾区研究人员的成核组
细胞内病原体和先天免疫。具体目的是:1)进行科学管理
进步; 2)建立并参与外部顾问委员会以审查科学进步; 3)实施
财务管理和行政支持。为了促进调查人员之间的互动,两个小时
联合实验室会议将继续在加州大学伯克利分校举行。这些每月会议包括
介绍性讨论和两个不同实验室的科学演示。给定可能的限制
与冠状病毒有关,我们将在必要时使用电信选项进行会议。
由UCLA的Jeffrey F. Miller博士主持的外部科学顾问委员会将提供严格的和
对计划的科学方向,研究结果和进步的一致评估。核心遗嘱
促进外部董事会与调查人员之间以及项目之间的关系
领导者本身,他们每月将在计划主任办公室开会2小时。 Portnoy,
万斯,考克斯和斯坦利实验室各自举行每周一次的实验室会议,以审查各自的研究
实验室。除了P01人员和其他湾区实验室的每月会议外,还有许多其他
调查人员和学员进行互动,交换想法和说话的机会,包括每周一次
免疫学和发病机理的“正在进行的研究”会议上午2月2日
来自两个不同实验室的演讲者;来自传染病和疫苗学组的开创性系列
星期一上午10点,大多数演讲者来自当地实验室;和微生物生物学研讨会系列,
星期三中午,来自美国和世界各地的发言人。最后,我们有一个年度
与UCSF共同举行的Asilomar的免疫学撤退。核心A充当行政核
对于P01,这是我们成功的关键要素。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
DANIEL A PORTNOY的其他基金
The role of Listeria cyclic-di-AMP during infection and immunity
李斯特菌环二腺苷在感染和免疫过程中的作用
- 批准号:82342258234225
- 财政年份:2011
- 资助金额:$ 17.48万$ 17.48万
- 项目类别:
Listeria-based vaccines engineered to modulate the innate immune system
基于李斯特菌的疫苗旨在调节先天免疫系统
- 批准号:82968018296801
- 财政年份:2011
- 资助金额:$ 17.48万$ 17.48万
- 项目类别:
Project 1: Listeria metabolites and innate immunity
项目1:李斯特菌代谢物与先天免疫
- 批准号:1019057810190578
- 财政年份:2004
- 资助金额:$ 17.48万$ 17.48万
- 项目类别:
Intracellular Pathogens and Innate Immunity
细胞内病原体和先天免疫
- 批准号:71772347177234
- 财政年份:2004
- 资助金额:$ 17.48万$ 17.48万
- 项目类别:
The intersection of innate and adaptive immunity to intracellular pathogens
针对细胞内病原体的先天免疫和适应性免疫的交叉点
- 批准号:1065528810655288
- 财政年份:2004
- 资助金额:$ 17.48万$ 17.48万
- 项目类别:
Intracellular pathogens and innate immunity
细胞内病原体和先天免疫
- 批准号:85071318507131
- 财政年份:2004
- 资助金额:$ 17.48万$ 17.48万
- 项目类别:
Project 1: Innate immune responses triggered by Listeria monocytogenes
项目1:单增李斯特菌引发的先天免疫反应
- 批准号:99771059977105
- 财政年份:2004
- 资助金额:$ 17.48万$ 17.48万
- 项目类别:
The intersection of innate and adaptive immunity to intracellular pathogens
针对细胞内病原体的先天免疫和适应性免疫的交叉点
- 批准号:1040017910400179
- 财政年份:2004
- 资助金额:$ 17.48万$ 17.48万
- 项目类别:
相似国自然基金
mRNA反式调控基因转录的机制及其生物学功能
- 批准号:32330018
- 批准年份:2023
- 资助金额:220 万元
- 项目类别:重点项目
增材制造锌镁合金复合椎间融合器降解调控机制与生物学效应研究
- 批准号:52301302
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
基于脑-脊髓-视神经MRI影像特征的神经免疫疾病影像亚型及其分子生物学机制的多组学研究
- 批准号:82330057
- 批准年份:2023
- 资助金额:220 万元
- 项目类别:重点项目
秸秆还田下玉/豆间作系统的生物固氮效应及微生物学机制
- 批准号:32301962
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
III-E型CRISPR-Cas系统的结构生物学及其应用研究
- 批准号:32371276
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Maternal Fetal Medicine Units Network: University of California, San Francisco
母胎医学单位网络:加州大学旧金山分校
- 批准号:1068287210682872
- 财政年份:2023
- 资助金额:$ 17.48万$ 17.48万
- 项目类别:
2023 Salmonella Biology and Pathogenesis Gordon Research Conference and Seminar
2023年沙门氏菌生物学与发病机制戈登研究会议暨研讨会
- 批准号:1068361710683617
- 财政年份:2023
- 资助金额:$ 17.48万$ 17.48万
- 项目类别:
Network-based analysis of disease-associated epigenetic changes in youth electronic cigarette users
基于网络的青少年电子烟使用者疾病相关表观遗传变化分析
- 批准号:1068030610680306
- 财政年份:2023
- 资助金额:$ 17.48万$ 17.48万
- 项目类别: